Global Chief Medical Officer at Legend Biotech

Franklin Township, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Accomplished drug developer
Visionary organization/business leader
Experience in clinical development
Expertise in cell and gene therapy
Experience with Phase I-IV studies
Knowledge of regulatory submissions
Experience with product commercialization

Responsibilities

Lead the global clinical development strategy and execution for the company’s pipeline
Oversee clinical trial design and execution, including Phase I-IV studies
Provide strategic direction and operational management for clinical teams across the US and China
Ensure the safety, efficacy, and regulatory compliance of the company’s innovative therapies
Shape the clinical vision for the company’s pipeline
Work closely with the executive leadership team, regulatory authorities, and key external stakeholders
Lead the clinical development program from pre-clinical stages through to post-market activities
Act as a strategic thought leader in the field of cell and gene therapy
Provide clinical expertise in the design, execution, and interpretation of clinical trials

Skills

Clinical Development

Immunotherapy

Cell Therapy

Drug Development

Global Strategy

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free